VTRS
Price
$9.68
Change
+$0.31 (+3.31%)
Updated
Dec 4, 6:59 PM EST
83 days until earnings call
ZOM
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
Dec 4, 6:59 PM EST
85 days until earnings call
Ad is loading...

Compare trend and price VTRS vs ZOM

Header iconVTRS vs ZOM Comparison
Open Charts VTRS vs ZOMBanner chart's image
Viatris
Price$9.68
Change+$0.31 (+3.31%)
Volume$7.33M
CapitalizationN/A
Zomedica
Price$0.17
Change-$0.00 (-0.00%)
Volume$1.31M
CapitalizationN/A
View a ticker or compare two or three
VTRS vs ZOM Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
VTRS vs. ZOM commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VTRS is a Buy and ZOM is a Hold.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (VTRS: $9.68 vs. ZOM: $0.17)
Brand notoriety: VTRS and ZOM are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: VTRS: 134% vs. ZOM: 88%
Market capitalization -- VTRS: $11.2B vs. ZOM: $167.08M
VTRS [@Pharmaceuticals: Other] is valued at $11.2B. ZOM’s [@Pharmaceuticals: Other] market capitalization is $167.08M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $82.08B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTRS’s FA Score shows that 1 FA rating(s) are green whileZOM’s FA Score has 0 green FA rating(s).

  • VTRS’s FA Score: 1 green, 4 red.
  • ZOM’s FA Score: 0 green, 5 red.
According to our system of comparison, VTRS is a better buy in the long-term than ZOM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VTRS’s TA Score shows that 7 TA indicator(s) are bullish while ZOM’s TA Score has 4 bullish TA indicator(s).

  • VTRS’s TA Score: 7 bullish, 3 bearish.
  • ZOM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than ZOM.

Price Growth

VTRS (@Pharmaceuticals: Other) experienced а +3.64% price change this week, while ZOM (@Pharmaceuticals: Other) price change was -1.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.75%. For the same industry, the average monthly price growth was +5.58%, and the average quarterly price growth was -5.21%.

Reported Earning Dates

VTRS is expected to report earnings on Feb 26, 2024.

ZOM is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+4.75% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for VTRS with price predictions.
OPEN
A.I.dvisor published
a Summary for ZOM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VTRS($11.2B) has a higher market cap than ZOM($167M). ZOM YTD gains are higher at: 2.638 vs. VTRS (-8.781). VTRS has higher annual earnings (EBITDA): 6.07B vs. ZOM (-11.94M). VTRS has more cash in the bank: 1.56B vs. ZOM (106M). ZOM has less debt than VTRS: ZOM (1.75M) vs VTRS (18.6B). VTRS has higher revenues than ZOM: VTRS (15.5B) vs ZOM (24M).
VTRSZOMVTRS / ZOM
Capitalization11.2B167M6,707%
EBITDA6.07B-11.94M-50,876%
Gain YTD-8.7812.638-333%
P/E Ratio6.05N/A-
Revenue15.5B24M64,583%
Total Cash1.56B106M1,475%
Total Debt18.6B1.75M1,061,644%
FUNDAMENTALS RATINGS
VTRS vs ZOM: Fundamental Ratings
VTRS
ZOM
OUTLOOK RATING
1..100
1460
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7492
PRICE GROWTH RATING
1..100
5571
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (1) in the null industry is somewhat better than the same rating for ZOM (53) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew somewhat faster than ZOM’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as ZOM (100) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to ZOM’s over the last 12 months.

VTRS's SMR Rating (74) in the null industry is in the same range as ZOM (92) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to ZOM’s over the last 12 months.

VTRS's Price Growth Rating (55) in the null industry is in the same range as ZOM (71) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to ZOM’s over the last 12 months.

VTRS's P/E Growth Rating (93) in the null industry is in the same range as ZOM (100) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to ZOM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VTRSZOM
RSI
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
67%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
57%
N/A
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSVTX15.43N/A
N/A
Goldman Sachs Large Cap Value Inv
PWJBX26.96N/A
N/A
PGIM Jennison International Opps R2
ADTAX22.46N/A
N/A
Allspring Dynamic Target 2065 A
MIEDX8.33-0.03
-0.36%
MassMutual International Eq R5
EEMAX11.83-0.08
-0.67%
Columbia Emerging Markets A

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with PRGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+3.31%
PRGO - VTRS
48%
Loosely correlated
+1.49%
TEVA - VTRS
41%
Loosely correlated
+3.30%
ELAN - VTRS
41%
Loosely correlated
+3.47%
PAHC - VTRS
37%
Loosely correlated
+13.88%
COLL - VTRS
33%
Loosely correlated
+2.34%
More